JP2013507442A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507442A5
JP2013507442A5 JP2012534272A JP2012534272A JP2013507442A5 JP 2013507442 A5 JP2013507442 A5 JP 2013507442A5 JP 2012534272 A JP2012534272 A JP 2012534272A JP 2012534272 A JP2012534272 A JP 2012534272A JP 2013507442 A5 JP2013507442 A5 JP 2013507442A5
Authority
JP
Japan
Prior art keywords
combination
days
pharmaceutically acceptable
acceptable salt
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2012534272A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013507442A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/052242 external-priority patent/WO2011046894A1/en
Publication of JP2013507442A publication Critical patent/JP2013507442A/ja
Publication of JP2013507442A5 publication Critical patent/JP2013507442A5/ja
Ceased legal-status Critical Current

Links

JP2012534272A 2009-10-12 2010-10-12 組合せ Ceased JP2013507442A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25063509P 2009-10-12 2009-10-12
US61/250,635 2009-10-12
PCT/US2010/052242 WO2011046894A1 (en) 2009-10-12 2010-10-12 Combination

Publications (2)

Publication Number Publication Date
JP2013507442A JP2013507442A (ja) 2013-03-04
JP2013507442A5 true JP2013507442A5 (https=) 2013-10-24

Family

ID=43876468

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012534272A Ceased JP2013507442A (ja) 2009-10-12 2010-10-12 組合せ

Country Status (13)

Country Link
US (1) US20120202822A1 (https=)
EP (1) EP2488184A4 (https=)
JP (1) JP2013507442A (https=)
KR (1) KR20120097496A (https=)
CN (1) CN102665720A (https=)
AU (1) AU2010307043C1 (https=)
BR (1) BR112012008519A2 (https=)
CA (1) CA2777561A1 (https=)
EA (1) EA020965B1 (https=)
IL (1) IL219103A0 (https=)
MX (1) MX2012004259A (https=)
WO (1) WO2011046894A1 (https=)
ZA (1) ZA201202416B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013545756A (ja) * 2010-11-16 2013-12-26 グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー2、リミテッド 投与および治療方法
TR201904980T4 (tr) 2012-08-07 2019-05-21 Novartis Ag Bir B-Raf inhibitörü, bir EGFR inhibitörü ve isteğe bağlı olarak bir PI3K-alfa inhibitörü içeren farmasötik kombinasyonlar.
DK2884979T3 (da) 2012-08-17 2019-09-02 Hoffmann La Roche Kombinationsbehandlinger mod melanom omfattende indgivelse af cobimetinib og vemurafenib
CN103936728B (zh) * 2013-01-18 2016-08-10 通化济达医药有限公司 噻唑激酶抑制剂
CN103936730A (zh) * 2013-01-22 2014-07-23 通化济达医药有限公司 苯磺酰胺噻唑激酶抑制剂
CN103965180B (zh) * 2013-01-24 2016-09-07 通化济达医药有限公司 苯磺酰胺噁唑和噻唑激酶抑制剂
WO2014158467A1 (en) * 2013-03-12 2014-10-02 Glaxosmithkline Llc Combination
UA118846C2 (uk) 2013-03-21 2019-03-25 Новартіс Аг Комбінована терапія
CN104540822B (zh) * 2013-07-08 2016-08-31 杭州普晒医药科技有限公司 达拉菲尼甲磺酸盐的晶型及其制备方法
JP6727127B2 (ja) * 2013-12-20 2020-07-29 バイオメッド バレー ディスカバリーズ,インコーポレイティド Pi3k/aktシグナル経路阻害剤およびerk阻害剤の組み合わせを使用するがん処置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2349832A1 (en) * 1999-01-13 2000-07-20 Warner-Lambert Company Benzenesulfonamide derivatives and their use as mek inhibitors
US7691377B2 (en) * 2004-04-16 2010-04-06 Rutgers, The State University Of New Jersey Methods and compositions for treating melanoma
US8835473B2 (en) * 2004-04-16 2014-09-16 Rutgers, The State University Of New Jersey Methods and compositions for treating cancer
MY149143A (en) * 2006-01-18 2013-07-15 Amgen Inc Thiazole compounds as protien kinase b (pkb) inhibitors
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
UA103319C2 (en) * 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds

Similar Documents

Publication Publication Date Title
JP2013507442A5 (https=)
JP2017528507A5 (https=)
JP2017528503A5 (https=)
JP2014532647A5 (https=)
JP2013525444A5 (https=)
JP2017504611A5 (https=)
JP2012184234A5 (https=)
JP2011522816A5 (https=)
JP2013531028A5 (https=)
JP2013522326A5 (https=)
RU2011108026A (ru) Комбинированная терапия туберкулеза
JP2014526503A5 (https=)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
JP2013507415A5 (https=)
JP2010530376A5 (https=)
JP2012533546A5 (https=)
JP2014505107A5 (https=)
JP2017222722A5 (https=)
JP2008534453A5 (https=)
JP2010532314A5 (https=)
JP2019531356A5 (https=)
JP2019218379A5 (https=)
JP2009504774A5 (https=)
JP2020515523A5 (https=)
JP2020500868A5 (https=)